RestorGenex Corp, formerly Stratus Media Group, Inc., is a biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women�s health. The Company�s proposed product portfolio includes a cosmeceutical product line. The Company is engaged in product development for both the cosmeceutical market, as well as the prescription dermatology market. The Company�s opthalmology business is based upon developing a non-steroidal, synthetic, small molecule drug library through computational design, and synthetic and medicinal chemistry, resulting in a family of agents, called Palomids. The Company also is engaged in the prescription women�s health business. Effective June 30, 2013, the Company suspended development of its ProElite, Inc. (ProElite) mixed martial arts (MMA). On March 28, 2014, the Company acquired Paloma Pharmaceuticals, Inc and VasculoMedics, Inc.